Delivery Order SPE2DB20D3111-SPE2DB26FA5RP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,642.86 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (90-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pioglitazone HCL 45 mg tablets in quantities of 500 units, with a ceiling value of $1,010.78. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units) valued at $2,474.49. This non-competitive delivery order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a firm fixed-price transaction under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Pioglitazone HCL 15 mg tablets (30-count units) with a ceiling value of $1,142.37 and a firm fixed price structure. The order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date is set for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,804.19 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pioglitazone HCL 30 mg tablets in a quantity of 500 units. This is a firm fixed-price delivery order valued at $1,502.62, with an ultimate completion date of September 23, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 90 units. This contract is a firm fixed-price delivery order with a ceiling value of $4,167.80 and an ultimate completion date of September 2, 2025. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pioglitazone HCL 15 mg tablets in a quantity of 90 count, valued at $1,904.05. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of October 22, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,663.37 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 15 mg tablets (90-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitively awarded delivery order procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $6,417.35. This firm fixed-price delivery order, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pioglitazone is a diabetes management medication commonly...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB26FA5RPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Pioglitazone HCL 45 mg tablets (90-count unit) valued at $1,525.49. This firm fixed-price delivery order is set to be completed by November 7, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen serves as a major pharmaceutical distributor providing critical medical commodities including brand-name and generic medications, vaccines, and specialized healthcare products to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical supply requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/6/25 |